Skip to main content

Hollings Horizons

Hollings Horizons is MUSC Hollings Cancer Center’s bi-annual magazine featuring the innovative and inspiring work happening in our clinics, labs, and community.

Hollings Horizons Summer/Fall 2026 magazine cover with a boy hugging a dog and text about highlighted articles with another magazine on top of it open to the story about the boy's battle with a rare cancer
a mother and child smile happily

Watch Luke Strong's extraordinary journey from life-threatening cancer diagnosis to hopeful recovery – one that would test modern medicine, unite dozens of specialists and culminate in complex, lifesaving surgery. Read more about Luke's story

[A young woman struggles to contain a wriggly little boy in her lap as they sit in front of a stained glass window mosaic portraying a live oak]

(Allie Strong): Our world just flipped upside down, like that fast. Never expected, like, a tumor or any of that.

[Upbeat music plays over MUSC Hollings Cancer Center logo. Snapshots fill the screen of the little boy and girl with baby sister, the boy in a Halloween costume, the boy with his father on a baseball field ]

Luke is our oldest son. He likes to play outside. He likes anything boy – trucks, tractors, balls.

[Allie and Luke walk along a landscaped play area as he swings part of his medical gear like a sword]

He's really into sword fighting and reptiles right now. And he is super sweet. He's like the sweetest little boy.

[Snapshots of Luke in the hospital]

Last year on Mother's Day he was just, like, screaming in pain all night. And I was like, this is not usual. He was just saying “my belly.” So we went to the E.R.

[Screen displays: “After weeks of symptoms and two trips to the ER, doctors found that Luke had pancreatoblastoma. Pancreatoblastoma is a rare pancreatic cancer that primarily affects young children.”]

(Dr. Kevin Roggin) [Dr. Roggin sits at his desk]: I remember when we first talked about his case, it was like, I don't know how we could possibly do an operation that would effectively remove his tumor.

[Snapshots of Luke acting goofy with his IV pole, hanging out with nurses for his birthday, and laying in his hospital bed]

We kept surgery on the table as an option to see but none of us really felt like that was the best option.

And it's only after, you know, his really dedicated team of oncologists at Shawn Jenkins that kept pushing the envelope in terms of systemic therapies. And when we sort of reached a point where we felt like the tumor was as small as it was going to be and we then decided to put together a multidisciplinary team.

And together we mapped out a plan to try to remove Luke's tumor.

[Screen displays: “That plan included a Whipple procedure – a complex surgery to remove the head of the pancreas, duodenum, gallbladder and bile duct to treat the tumor. It is a rare, high-stakes surgery for children.”]

(Allie)[Allie and Luke in front of the stained glass]: I was a little nervous being that, like, Dr. Roggin is an adult, like primarily an adult [doctor]. But he has been excellent. He's, like, been top tier. Like, he was just so great with Luke. And, we're very grateful.

[Dr. Roggin in his office]: Most of our experience in this specific operation is in the adult population and in my career – over 20 something years, the range that I had operated on was 14 to 91. So Luke represents the youngest case that I've done.

[Luke and his mother play in the outdoor play area]

It's an operation that is one of the most complex operations we do in abdominal surgical oncology. I always describe it to patients as it's like kind of the Boardwalk and Park Place of the body, where it's really high-priced real estate, and there's a lot of structures that we need to preserve.

[Dr. Roggin in his office]

And in Luke's case, because he had had a longstanding tumor and blockage of the venous drainage back to his liver, in order to take out his tumor, we had to separate all those connections that his body, you know, made to return blood because it was blocked.

[Allie and Luke in front of the stained glass]

(Allie): When Dr. Roggin and Dr. Cina came and told us, “Hey, it's done. Like the tumor peeled away and we didn't have to touch the vein.” I was like, I was just astonished. I was like, “Wow, this is amazing.”

[Snapshots of Luke in the hospital, snuggling with dad and of a large group of supporters in the lobby]

(Dr. Roggin): Instead of worrying about the playground and all these other things, Luke was, you know, in and out of the hospital.

But what, you know, what struck me about him and his family is how optimistic they were, how much they were people of faith, and they had such a strong, supportive community that sort of rallied behind Luke.

[Screen displays, “The Strongs hope to take this challenge and turn it into something good.]

(Allie): We would just like to see for him to complete this oral chemo and hopefully, maybe start school next year. And to get on with life and – yeah, just...I hope that he can use this to help other people. And that's how I've looked at it is I want to be able to use our experience to help other people – other families going through stuff like this.

(Roggin): You know, Luke's a special boy, has got a special family and they obviously were dealt a very difficult hand. But what was unique about their family and their support was that they really had faith that, you know, they were in the right place and the right hands.

And it made everyone's job easier because we, we sort of felt like they understood and they were so grateful for, you know, anything that we could do to help Luke that it made it easy to work with them.

And it was a really high point for our team to go in there and, you know, see Luke at the different stages of recovery.

[Cell phone video of Luke and Dr. Roggin play sword fighting in a hospital room]

And, Luke is a sword fighter. He is – that's his thing. And so, I was able to to participate. And I will say that Luke definitely defeated his surgeon with his sword fighting skill, but it was a fun part of, you know, getting to see him. When he could get back to sword fighting, that's when I knew it was going to be better.

[MUSC Hollings Cancer Center logo]

MUSC cancer center building rendering for conceptual use only
MUSC is building a new, state-of-the-art comprehensive cancer hospital that will provide innovative care for patients in Charleston and across the state.

Raymond N. DuBois, M.D., Ph.D.

Director, Hollings Cancer Center Associate Provost for Cancer Programs Professor, Biochemistry & Molecular Biology

Director's Message

Summer/Fall 2026

I’m often asked about the most important advances in cancer research today. Many people expect me to point to new treatments — and those are certainly important and a priority at Hollings Cancer Center. But one area that deserves just as much attention, and is often overlooked, is cancer prevention. It’s just as complex as treatment and ultimately has the potential to save more lives.

Cancer develops slowly over time, influenced by factors like inflammation, the immune system, metabolism, aging, environmental exposures and genetics. As our understanding of these processes grows, so does our ability to prevent cancer before it starts.

At the same time, new technologies are helping us detect very early changes in the body. Advances in blood-based tests, imaging and data analysis allow us to identify people at higher risk and intervene sooner. This is what we call “precision prevention,” moving away from a one-size-fits-all approach toward more personalized strategies.

We are also seeing promising new directions in areas like immunology. The same types of approaches that help the immune system fight advanced cancers may eventually help prevent them from developing at all.

Many cancers are influenced by lifestyle and environmental factors, which means there are steps individuals can take to reduce their risk. It’s important for everyone to work with their doctors to understand which cancer screenings are appropriate and when to receive them. By combining scientific advances with personal responsibility, we can make meaningful strides toward a future with less cancer.

Research News

Targeting tumor relapse in pediatric brain cancer

Hollings researcher Jezabel Rodriguez Blanco, Ph.D., identified a potential way to reduce relapse in medulloblastoma, an aggressive childhood cancer.

Read More
Jezabel Rodriguez Blanco pauses in her work in her lab.
"This is about going after the root of relapse. If we can do that, we have a real chance to change outcomes for these kids."
A junior researcher sits at a microscope station while her mentor stands behind her to look at the screen.
Graduate student Jenna Schwesig and researcher Denis Guttridge, Ph.D., are working to uncover the cellular processes that lead to muscle loss in cancer.

Tackling pancreatic cancer’s drain on the body

The muscle-wasting condition known as cachexia affects about half of all cancer patients but is especially prominent in pancreatic cancer. Hollings researchers have uncovered inflammatory signals that may drive this muscle loss.

Read More

Rewiring the urge to smoke

Researchers at Hollings are investigating using rTMS, a noninvasive brain stimulation technique, to help people to quit smoking. Their study found that stimulating a specific brain region that regulates self-control significantly reduced how much people smoked.

Read More
A man sits with a strap around his forehead and a large sensor attached to a wand perched atop his head while behind him a woman looks at a computer monitor displaying images of his brain.
Xingbao Li, M.D., demonstrates how someone would receive rTMS therapy to reduce nicotine cravings.
a researcher leans over to look at her computer in the lab
Paczesny said her team made their new tool, BIOPREVENT, freely available so that other researchers and clinicians could test it and learn from it.

AI tool can predict serious transplant complications

Hollings researcher Sophie Paczesny, M.D., Ph.D., led a team that developed an AI tool that uses blood biomarkers to better predict which stem cell and bone marrow transplant patients will suffer from chronic graft-versus-host disease, opening the door to earlier monitoring.

Read More

Subscribe to Hollings news

Keep up with the latest Hollings news by signing up for our monthly e-newsletter or subscribing to receive Hollings Horizons in print.

Subscribe